New transplant recipe may tame severe anemia
NCT ID NCT06837987
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study reviews a modified transplant conditioning regimen for severe aplastic anemia in 72 patients across two hospitals. The approach uses a combination of fludarabine, melphalan, and cyclophosphamide to prepare the body for a stem cell transplant. Researchers looked at how well the transplant took and how many patients developed graft-versus-host disease, a common complication.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- modified transplantation conditioning (fludarabine, melphalan, cyclophosphamide)
- What this could lead to
- If successful, this modified transplant approach could offer a safer and more effective way to treat severe aplastic anemia, reducing complications like graft failure and graft-versus-host disease.
- What could go wrong
- This is a small, retrospective study with no control group, so results may not apply to all patients. Transplant procedures carry risks such as infection, organ damage, and graft failure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for APLASTIC ANAEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Hematology，920th Hospital of Joint Logistics Support Force
Kunming, Yunnan, 650000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New hope for older adults with rare blood disorder: safer transplant regimen under study
- New combo therapy for rare blood disorder shows promise
- Double stem cell transplant could be Game-Changer for rare blood disorder
- New study aims to tame harsh side effects of aplastic anemia therapy
- New study: which first treatment works best for severe aplastic anemia?